The weakening of the immune system caused by a measles infection is so severe that it makes it difficult to defend against other pathogens for months to years after infection. This increases the risk of developing complications such as bronchitis, middle ear and larynx infections, bronchitis or gastrointestinal infections. The probability of suffering from one of these sequelae is 20%.
In 1-2 people per 1,000 who fall ill, a so-called measles encephalitis (inflammation of the brain) can occur. One third of those affected by this secondary disease suffer permanent damage such as mental disabilities or paralysis, and about 10-20% of those who contract the disease die.
In rare cases, approximately 5 in 10,000 cases, subacute sclerosing panencephalitis (SSPE) may occur. This complication, which is always fatal, can also occur with a delay of 6 to 8 years after a measles infection. In this so-called "slow-virus" measles infection, the white matter of the brain degrades continuously. Children who contract measles at birth or in the first year of life are particularly susceptible to SSPE.
Since there is no specific treatment for measles, the infection is mostly treated symptomatically, for example with antipyretic or analgesic drugs. Despite high vaccination rates in the D-A-CH region, infections still occur frequently in unprotected individuals. Vaccination with the widely tested and well-tolerated combination vaccine against measles-mumps-rubella is the only effective measure to protect against infection.
Vaccination situation and vaccination behavior
The past decades have shown that the spread of infectious diseases such as measles can be halted by widespread immunization. Nevertheless, the vaccination coverage rate in Austria is not high enough to provide sufficient community protection and even seems to be steadily declining, as an evaluation by the Ministry of Health shows.
Although the number of vaccinations had only fallen by just under 5%, this decline mainly affects young children. Compared to 2020, when 95% of 2-year-olds received at least the first and 88% the second partial vaccination, the following year for the same age group, vaccination coverage rates were only 84% for the first and 74% for the second partial vaccination. Vaccination rates in 2021 are somewhat higher among slightly older children (2 to 5-year-olds), at 95% for the first and 88% for the second partial vaccination. Even among 6- to 9-year-olds, the 95% target will be reached only for the first partial vaccination. In contrast, herd protection continued to be maintained for both partial vaccinations in the 10 to 18-year-old age group. In the young adult age group, there is again insufficient vaccine protection with both partial vaccinations.